Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
Saturday, September 12, 2009
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Friday, September 11, 2009
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron ends Phase 3 trial for pancreatic cancer treatment - Albany Times Union
Albany Times Union
The company announced the discontinuation of the trial after the markets closed. In after-hours trading, shares were off another 88 cents to $21.00.
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Sanofi-Aventis, Regeneron End Phase III Trial Of Aflibercept - Wall Street Journal
Wall Street Journal
Shares of Regeneron fell 3% to $21.23 in after-hours trading. Sanofi-Aventis' American depositary shares closed Friday at $35.05, up 0.4%, and were inactive ...
and more »
Regeneron, Sanofi drug fails against pancreatic cancer - Forexyard
Forexyard
Shares of Regeneron, a biotechnology company based in Tarrytown, New York, fell almost 5 percent in after-hours trading, from their closing price on Friday ...
and more »
Subscribe to:
Comments (Atom)
